Equity | Note 6. Equity The Company is currently authorized to issue up to 200,000,000 0.0001 20,000,000 0.0001 2022 On February 8, 2022, the Board approve the issuance of 2,975,000 445,953 On June 19, 2022, the Company entered into a one-year contract with SRAX, Inc. (“SRAX”). In exchange for the right to use the SRAX Sequire platform, in connection with the Company’s Regulation A Offering, the Company will issue SRAX 1,250,000 shares of its restricted common stock. Per the agreement, the shares are subject to a price adjustment if the Company issues any common stock or common stock equivalents less than $1.00 per share. On July 13, 2022, the Company issued 1,250,000 1,250,000 677,083 572,917 On December 14, 2022, the Board approved the issuance of 600,000 599,940 During the year ended December 31, 2022, the Company issued 2,000 1,990 2021 During the year ended December 31, 2021, the Company issued 7,525,000 752 During the year ended December 31, 2021, the Company issued 10,000,000 During the year ended December 31, 2021, the Company issued 34,375,000 2,478 960 5,152,813 During the year ended December 31, 2021, the Company sold 29.75 Units 595,000 Each Unit consists of 100,000 shares of our common stock and 50,000 warrants. On December 1, 2021, the Company entered into an agreement with Manhattan Street Capital (“MSC”) to provide management, technology, administrative services, and assistance with and introduction to resources need to conduct a Reg A+ offering. MSC with be paid $5,000 monthly in advance for a 9-month period and $2,500 per month while the offering is ongoing. In addition, MSC will receive 2,000,000 300,000 300,000 0 300,000 Stock Warrants The following table summarizes the stock warrant activity for the years ended December 31, 2022 and 2021: Schedule of stock warrant activity Number of Weighted Average Exercise Price Per Share Outstanding at December 31, 2020 – $ – Granted 1,487,500 2.00 Exercised – – Forfeited and expired – – Outstanding at December 31, 2021 1,487,500 2.00 Granted – – Exercised – – Forfeited and expired – – Outstanding at December 31, 2022 1,487,500 $ 2.00 As of December 31, 2022, all outstanding warrants are exercisable and have a weighted average remaining term of 2.0 no Stock Options The following table summarizes the stock option activity for the years ended December 31, 2022 and 2021: Schedule of stock option activity Number of Options Weighted Average Exercise Price Per Share Outstanding at December 31, 2020 – $ – Granted 3,750,000 0.10 Exercised – – Forfeited and expired – – Outstanding at December 31, 2021 3,750,000 0.10 Granted 300,000 0.20 Exercised – – Forfeited and expired – – Outstanding at December 31, 2022 4,050,000 $ 0.11 On December 14, 2022, the Company granted 300,000 0.20 43,048 1.00 0.20 10 126.98 3.49 0 On August 1, 2021, the Company granted 2,000,000 1,750,000 0.10 732,508 0.20 0.10 10 132.91 1.24 0 During the year ended December 31, 2022, the Company recognized $ 252,373 673,781 8.69 187,500 During the year ended December 31, 2021, the Company recognized $ 101,737 630,771 |